The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.

导出 LinkOut

翻译打印收藏纠错

作者： Wei,Zhang ^[1] ; Bingyu,Chen ^[2] ; Yu,Zhang ^[3] ; Kaiqiang,Li ^[2] ; Ke,Hao ^[2] ; Luxi,Jiang ^[2] ; Ying,Wang ^[2] ; Xiaozhou,Mou ^[3] ; Xiaodong,Xu ^[4] ; Zhen,Wang ^[5]

作者单位： Department of Gastrointestinal Pancreatic Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China; Research Center of Blood Transfusion Medicine, Education Ministry Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China. ^[1] Research Center of Blood Transfusion Medicine, Education Ministry Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China. ^[2] Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China. ^[3] Department of Gastrointestinal Pancreatic Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China. Electronic address: drxxklzjsry@163.com. ^[4] Research Center of Blood Transfusion Medicine, Education Ministry Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou medical College, Hangzhou, China. Electronic address: drzwklzjsry@163.com. ^[5]

关键词 Apoptosis CZ415 Hepatocellular carcinoma Mammalian target of rapamycin (mTOR)